Back to 
UBS Group AG
UBS Group AG
PPCB
2 quarters
Position history for UBS Group AG's holdings in Propanc Biopharma, Inc.
No. Ubs exited its PPCB (Propanc Biopharma) position in Q2 2026. Its Q1 2026 13F listed 182,614 shares worth $19,357. Ubs first reported PPCB in Q1 2026 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$19,357
Total Shares Change
-182,614
Quarter-by-Quarter History
Other major holders of PPCB: Marex Group Ltd, Virtu Financial LLC, Jane Street Group, LLC, XTX Topco Ltd